患有阿尔茨海默氏症的患者的免疫系统相关基因
Rui Yao1, Ziyu Ouyang1, Tianyan Xu1
1Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Journal of Alzheimer's disease : JAD
|August 6, 2025
概括
这项研究将APOE,ABCA7,SAMD9和HRH1等与免疫相关的基因与阿尔茨海默病 (AD) 风险联系起来. 在SAMD9影响免疫路径的遗传变异,表明在AD的发病过程中发挥了作用.
科学领域:
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
背景情况:
- 阿尔茨海默氏病 (AD) 的发病因子越来越多地与免疫系统失调有关.
- 免疫相关基因在AD风险和进展中的特定作用仍然不完全理解.
研究的目的:
- 系统地调查一组综合免疫相关基因与阿尔茨海默病风险之间的关联.
- 探索已识别的基因变异对免疫路径和AD病变的功能影响.
主要方法:
- 全基因组测序 (WGS) 在1516名阿尔茨海默病患者和2010年的对照组中.
- 对8260个免疫相关基因的常见和罕见变异进行遗传关联分析.
- 用等离子体生物标志物进行分子对接,RNA测序和多基因风险评分 (PRS) 分析.
主要成果:
- 在APOE和ABCA7中常见的变异显示出与AD的显著关联.
- 在SAMD9 (F222L,I1389T) 和HRH1中罕见的误解变异与AD和血Aβ42/Aβ40比率有暗示的联系.
- SAMD9 F222L变种在免疫相关途径上表现出功能丧失影响;PRS与AD生物标志物 (NfL,ptau,GFAP) 相相关.
结论:
- 在APOE,ABCA7中常见的变异,以及SAMD9和HRH1的罕见变异与阿尔茨海默病风险有关.
- SAMD9 F222L变体对免疫基因表达的影响表明它在AD病变发生过程中发挥了作用.
- 与免疫相关的基因PRS强调了免疫系统对阿尔茨海默病的贡献,特别是在中国人群中.
相关概念视频
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262


